Access the full text.
Sign up today, get DeepDyve free for 14 days.
A. Loginova, N. Pospekhova, L. Lyubchenko, A. Budilov, V. Zakhar'ev, R. Gar’kavtseva, E. Ginter, A. Karpukhin (2003)
Spectrum of Mutations in BRCA1 Gene in Hereditary Forms of Breast and Ovarian Cancer in Russian FamiliesBulletin of Experimental Biology and Medicine, 136
D. Easton, J. Hopper, Duncan Thomas, A. Antoniou, P. Pharoah, A. Whittemore, R. Haile (2004)
Breast Cancer Risks for BRCA1/2 CarriersScience, 306
S. Narod (2002)
Modifiers of risk of hereditary breast and ovarian cancerNature Reviews Cancer, 2
M. King, J. Marks, Jessica Mandell (2003)
Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2Science, 302
H. Yazici, O. Bitisik, E. Akisik, N. Cabioğlu, P. Saip, M. Muslumanoglu, G. Glendon, E. Bengisu, S. Ozbilen, M. Dinçer, S. Turkmen, I. Andrulis, N. Dalay, H. Ozçelik (2000)
BRCA1 and BRCA2 mutations in Turkish breast/ovarian families and young breast cancer patientsBritish Journal of Cancer, 83
Charlotte Sun, P. Ramirez, D. Bodurka (2007)
Quality of life for patients with epithelial ovarian cancerNature Clinical Practice Oncology, 4
A. Jasińska, W. Krzyzosiak (2001)
Prevalence of BRCA1 founder mutations in western PolandHuman Mutation, 17
P. Chan, B. Wong, H. Ozçelik, D. Cole, D. Cole (1999)
Simple and rapid detection of BRCA1 and BRCA2 mutations by multiplex mutagenically separated PCR.Clinical chemistry, 45 8 Pt 1
F. Eisinger, B. Bressac, D. Castaigne, P. Cottu, J. Lansac, J. Lefranc, A. Lesur, C. Noguès, J. Pierret, S. Puy‐Pernias, H. Sobol, A. Tardivon, H. Tristant, R. Villet (2004)
Identification et prise en charge des prédispositions héréditaires aux cancers du sein et de l‘ovaire (mise à jour 2004)Bulletin Du Cancer, 91
A. Antoniou, P. Pharoah, S. Narod, H. Risch, J. Eyfjord, J. Hopper, N. Loman, Hampus Olsson, O. Johannsson, Å. Borg, B. Pasini, P. Radice, S. Manoukian, D. Eccles, N. Tang, E. Oláh, H. Anton-Culver, E. Warner, J. Lubiński, J. Gronwald, B. Górski, H. Tulinius, S. Thorlacius, H. Eerola, H. Nevanlinna, K. Syrjäkoski, O. Kallioniemi, Deborah Thompson, Chris Evans, J. Peto, F. Lalloo, D. Evans, D. Easton (2003)
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.American journal of human genetics, 72 5
E. Grzybowska, M. Siemińska, H. Zientek, E. Kalinowska, J. Michalska, B. Utracka-Hutka, J. Rogozińska-Szczepka, Maria Kaźmierczak-Maciejewska (2002)
Germline mutations in the BRCA1 gene predisposing to breast and ovarian cancers in Upper Silesia population.Acta biochimica Polonica, 49 2
Y. Miki, J. Swensen, D. Shattuck-Eidens, P. Futreal, K. Harshman, S. Tavtigian, Qingyun Liu, C. Cochran, L. Bennett, W. Ding, R. Bell, J. Rosenthal, C. Hussey, Thanh Tran, M. Mcclure, C. Frye, T. Hattier, R. Phelps, A. Haugen-Strano, H. Katcher, Kazuko Yakumo, Z. Gholami, Daniel Shaffer, S. Stone, Steven Bayer, Christian Wray, R. Bogden, P. Dayananth, J. Ward, P. Tonin, S. Narod, Pamela Bristow, F. Norris, L. Helvering, P. Morrison, P. Rosteck, Mei Lai, J. Barrett, C. Lewis, S. Neuhausen, L. Cannon-Albright, D. Goldgar, R. Wiseman, A. Kamb, M. Skolnick (1994)
A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.Science, 266 5182
F. Eisinger, B. Bressac, D. Castaigne, P. Cottu, J. Lansac, J. Lefranc, A. Lesur, C. Noguès, J. Pierret, Séverine Puy‐Pernias, H. Sobol, A. Tardivon, H. Tristant, R. Villet (2004)
[Identification and management of hereditary predisposition to cancer of the breast and the ovary (update 2004)].Bulletin du cancer, 91 3
E. Honrado, J. Benítez, J. Palacios (2005)
The molecular pathology of hereditary breast cancer: genetic testing and therapeutic implicationsModern Pathology, 18
N. Uhrhammer, S. Bornes, Y. Bignon (2005)
Quelle place tiennent les gènes BRCA1 et BRCA2 dans les risques héréditaires de cancer de l’ovaire?Oncologie, 7
T. Walsh, S. Casadei, Kathryn Coats, E. Swisher, S. Stray, Jake Higgins, Kevin Roach, Jessica Mandell, Ming Lee, S. Ciernikova, L. Foretova, P. Souček, M. King (2006)
Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer.JAMA, 295 12
N. Kauff (2008)
Is It time to stratify for BRCA mutation status in therapeutic trials in ovarian cancer?Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 26 1
M. Looij, C. Szabo, I. Besznyák, Gyorgy Liszka, B. Csókay, T. Pulay, J. Tóth, P. Devilee, M. King, E. Oláh (2000)
Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in HungaryInternational Journal of Cancer, 86
O. Oszurek, B. Górski, J. Gronwald, Z. Prosolow, K. Uglanica, A. Murinow, I. Bobko, O. Downar, M. Zlobicz, D. Norik, T. Byrski, A. Jakubowska, J. Lubiński (2001)
Founder mutations in the BRCA1 gene in west Belarusian breast‐ovarian cancer familiesClinical Genetics, 60
R. Bar-Sade, A. Kruglikova, B. Modan, E. Gak, G. Hirsh-Yechezkel, L. Theodor, I. Novikov, R. Gershoni-baruch, S. Risel, M. Papa, G. Ben-Baruch, E. Friedman (1998)
The 185delAG BRCA1 mutation originated before the dispersion of Jews in the diaspora and is not limited to Ashkenazim.Human molecular genetics, 7 5
B. Górski, T. Byrski, T. Huzarski, A. Jakubowska, J. Menkiszak, J. Gronwald, A. Płużańska, M. Bębenek, Ł. Fischer-Maliszewska, E. Grzybowska, S. Narod, J. Lubiński (2000)
Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer.American journal of human genetics, 66 6
M. Zelen (2005)
Risks of cancer and families.Journal of the National Cancer Institute, 97 21
S. Ciernikova, M. Tomka, M. Kovác, V. Stevurková, V. Zajac (2006)
Ashkenazi founder BRCA1/BRCA2 mutations in Slovak hereditary breast and/or ovarian cancer families.Neoplasma, 53 2
M. FitzGerald, D. Macdonald, M. Krainer, I. Hoover, Erin O'Neil, Hilal Unsal, Sandra Silva-Arrieto, D. Finkelstein, P. Beer-Romero, C. Englert, D. Sgroi, Barbara Smith, J. Younger, J. Garber, R. Duda, K. Mayzel, K. Isselbacher, S. Friend, D. Haber (1996)
Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer.The New England journal of medicine, 334 3
J. Ferlay, P. Pisani, D. Parkin (2001)
Globocan 2000 : cancer incidence, mortality and prevalence worldwide
H. Janiszewska, O. Haus, A. Lauda-Świeciak, M. Pasińska, R. Laskowski, W. Szymanski, B. Górski, J. Lubiński (2003)
Frequency of three BRCA1 gene founder mutations in breast/ovarian cancer families from the Pomerania–Kujawy region of PolandClinical Genetics, 64
A. Chetrit, G. Hirsh-Yechezkel, Y. Ben-David, F. Lubin, E. Friedman, S. Sadetzki (2008)
Effect of BRCA1/2 mutations on long-term survival of patients with invasive ovarian cancer: the national Israeli study of ovarian cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 26 1
A. Kataki, I. Gomatos, Nikolaos Pararas, Athanasios Armakolas, D. Panousopoulos, G. Karantzikos, D. Voros, George Zografos, Christos Markopoulos, Emmanuel Leandros, Manoussos Konstadoulakis (2005)
Identification of germline BRCA1 and BRCA2 genetic alterations in Greek breast cancer moderate‐risk and low‐risk individuals – correlation with clinicopathological dataClinical Genetics, 67
D Ford, DF Easton, J Peto (1995)
Estimates of the gene frequency of BRCA1 mutations and its contribution to breast and ovarian cancer incidenceAm J Hum Genet, 57
J. Bermejo, K. Hemminki (2006)
Re: Risks of cancer and families.Journal of the National Cancer Institute, 98 8
R. Wooster, S. Neuhausen, J. Mangion, Y. Quirk, D. Ford, N. Collins, K. Nguyen, S. Seal, T. Tran, D. Averill (1994)
Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13.Science, 265 5181
F Eisinger (2004)
Identification and management of hereditary predisposition to cancer of the breast and the ovaryBull Cancer, 91
D. Ford, D. Easton, J. Peto (1995)
Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence.American journal of human genetics, 57 6
Breast cancer is the most common cancer in women worldwide, including Romania, where its incidence has increased significantly during the last decade. Ovarian cancer is the fourth leading cause of mortality by cancer in women. BRCA1 and BRCA2 are major cancer predisposition genes, responsible for a large percentage of hereditary breast and ovarian cancer (HBOC) families. We investigated 17 patients from unrelated HBOC families in north-eastern Romania, screening for mutations in BRCA1 and BRCA2 by mutation-specific PCR and by dideoxy sequencing. We identified four BRCA1 and two BRCA2 mutations in the 17 families. The overall mutation frequency was 41% (7/17; 5 BRCA1 and 2 BRCA2). Two mutations (BRCA1 c.2241dupC and BRCA2 c.8680C>T) were novel and not listed in the BIC database. Two recurrent BRCA1 mutations (c.5266dupC and c.181T>G), previously described among Ashkenazi Jewish and Eastern European populations, were also found. Two unclassified variants (UV) were found, one of which was novel (BRCA2 c.4589A>G). Medical follow-up for mutation carriers was implemented. Our study is the first molecular investigation of the role of the BRCA genes in breast and ovarian cancer in Romania.
Familial Cancer – Springer Journals
Published: Jun 22, 2010
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.